MRD negativity as a treatment endpoint in CLL

MRD negativity as a treatment endpoint in CLL

VJHemOnc

1 year
46 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Measurable residual disease (MRD) negativity is an important treatment endpoint for many hematological malignancies and has the potential to be used to inform therapy cessation decision making. Here, Arnon Kater, PhD, of Universiteit Van Amsterdam, Amsterdam, Netherlands, gives an overview of the HOVON-141 trial (NCT03226301) that utilizes MRD negativity as an endpoint in patients with chronic lymphocytic leukemia (CLL) that are treated with a combination of venetoclax and ibrutinib. Prof. Kater also discusses the research looking at venetoclax and obinutuzumab as a pre-treatment to lower the risk of tumor lysis syndrome in patients with CLL. Prof. Kater was speaking from the 23rd Congress of the European Hematology Association (EHA) 2018, held in Stockholm, Sweden.
Up Next Autoplay
Phase 3 DUO Study @ospniguarda
Phase 3 DUO Study @ospniguarda
Category: Chronic Lymphocytic Leukemia
9 Views
Cancer-News 2 weeks
ASH 2016 Page 3 Maintenance Therapy in Chronic Lymphocytic Leukemia
ASH 2016 Page 3 Maintenance Therapy in Chronic Lymphocytic Leukemia
Category: Chronic Lymphocytic Leukemia
201 Views
cancergrace 5 months
ASH 2016 Page 2 Update on New Chronic Lymphocytic Leukemia Drugs
ASH 2016 Page 2 Update on New Chronic Lymphocytic Leukemia Drugs
Category: Chronic Lymphocytic Leukemia
92 Views
cancergrace 5 months
CLL, What is the significance of IGHV mutations and how are they assessed
CLL, What is the significance of IGHV mutations and how are they assessed
Category: Chronic Lymphocytic Leukemia
87 Views
cancergrace 5 months
Not Your Fathers CLL with Dr. John Pagel
Not Your Fathers CLL with Dr. John Pagel
Category: Chronic Lymphocytic Leukemia
114 Views
cancergrace 5 months
CLL, Is there a role still for chemo AND who should get chemo
CLL, Is there a role still for chemo AND who should get chemo
Category: Chronic Lymphocytic Leukemia
75 Views
cancergrace 5 months
CLL, FCR vs BR – Is One Better
CLL, FCR vs BR – Is One Better
Category: Chronic Lymphocytic Leukemia
178 Views
cancergrace 5 months
The Role of CAR-T Therapy in B-Cell Lymphomas
The Role of CAR-T Therapy in B-Cell Lymphomas
Category: Chronic Lymphocytic Leukemia
69 Views
obr 5 months
Outcomes from RESONATE Trial in Relapsed CLL
Outcomes from RESONATE Trial in Relapsed CLL
Category: Chronic Lymphocytic Leukemia
68 Views
obr 5 months
CLL-14 Data Trial in Chronic Lymphocytic Leukemia
CLL-14 Data Trial in Chronic Lymphocytic Leukemia
Category: Chronic Lymphocytic Leukemia
149 Views
obr 5 months